Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Monitoring Breast Cancer Tumor Response At Different Timepoints During Pre-Surgical Chemotherapy with Diffuse Optical Spectroscopic Imaging

Not Accessible

Your library or personal account may give you access


Diffuse Optical Spectroscopic Imaging (DOSI) provides non-invasive functional biomarkers that correlate with final pathological response to pre-surgical (neoadjuvant) chemotherapy in breast cancer patients that are measured at various timepoints throughout the therapy.

© 2010 Optical Society of America

PDF Article
More Like This
Breast Tumor Biochemical Responses to Neoadjuvant Chemotherapy can be Observed Using Diffuse Optical Spectroscopy

Albert Cerussi, Natasha Shah, Montana Compton, Amanda Durkin, Bruce Tromberg, David Hsiang, Rita Mehta, Choong Baick, and John Butler
MI6 Biomedical Topical Meeting (BIO) 2006

Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Using Dynamic Tomographic Optical Breast imaging (DTOBI)

Amir Y. Sajjadi, Steven J. Isakoff, Christy M. Wanyo, Qianqian Fang, Michelle C. Specht, Lidia Schapira, Beverly Moy, Aditya Bardia, David A. Boas, and Stefan A. Carp
BW4B.5 Biomedical Optics (BIOMED) 2014

Multispectral and phase-contrast diffuse optical tomography of breast cancer during neoadjuvant chemotherapy

Xiaoping Liang, Qizhi Zhang, Stephen Staal, Stephen Grobmyer, and Huabei Jiang
JMA81 Biomedical Optics (BIOMED) 2010


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an Optica member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access Optica Member Subscription

Select as filters

Select Topics Cancel
© Copyright 2022 | Optica Publishing Group. All Rights Reserved